Long-term clinical outcomes and cost-effectiveness of catheter vs thoracoscopic surgical ablation in long-standing persistent atrial fibrillation using continuous cardiac monitoring: CASA-AF randomized controlled trial.
Vennela BoyallaShouvik HaldarHabib KhanInes Kralj-HansWinston BanyaJoanne LordAnitha SatishkumarToufan BahramiAnthony De SouzaJonathan R ClagueDarrel P FrancisWajid HussainJulian W JarmanDavid G JonesZhong ChenNeeraj MedirattaJonathan HydeMichael LewisRaad MohiaddinTushar V SalukheVias MarkidesJames McCreadyDhiraj GuptaTom Wongnull nullPublished in: Heart rhythm (2024)
In symptomatic LSPAF, CA and SA were equally effective at achieving arrhythmia outcomes (freedom from AF/AT ≥30 seconds and ≥75% burden reduction) after a single procedure without antiarrhythmic drugs. However, SA is significantly more costly than CA.
Keyphrases
- atrial fibrillation
- catheter ablation
- randomized controlled trial
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- study protocol
- heart failure
- protein kinase
- left ventricular
- percutaneous coronary intervention
- minimally invasive
- robot assisted
- risk factors
- type diabetes
- systematic review
- clinical trial
- metabolic syndrome
- skeletal muscle
- glycemic control
- venous thromboembolism
- drug induced